Squamous cell carcinoma often harbors BRAF mutations, and this is of particular importance, since patients with BRAF-mutant anaplastic thyroid carcinoma can benefit from treatment with targeted drugs [19]. Here, BRAF is linked to thyroid gland undifferentiated (anaplastic) carcinoma.